ArticleJournal of thoracic disease2021

Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II study.

Haiyu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.